Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,723 | 6,029 | 2,151 | 3,406 | 6,873 |
| Marketable Securities | N/A | N/A | 2,004 | 2,002 | N/A |
| TOTAL | $4,966 | $6,228 | $4,269 | $5,574 | $7,101 |
| Non-Current Assets | |||||
| PPE Net | 14 | 12 | 18 | 26 | 45 |
| Other Non-Current Assets | 9 | 9 | 11 | 11 | 11 |
| TOTAL | $23 | $21 | $29 | $36 | $56 |
| Total Assets | $4,989 | $6,249 | $4,298 | $5,610 | $7,156 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 350 | 264 | 174 | 478 | 425 |
| Accrued Expenses | 529 | 570 | 249 | 178 | 437 |
| TOTAL | $879 | $834 | $423 | $656 | $862 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,393 | 1,655 | 0 | 0 | 11 |
| TOTAL | $1,393 | $1,655 | $N/A | $N/A | $11 |
| Total Liabilities | $2,272 | $2,489 | $423 | $656 | $873 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,742 | 24,742 | 24,701 | 21,655 | 21,655 |
| Common Shares | 25 | 25 | 22 | 22 | 22 |
| Retained earnings | -39,192 | -38,103 | -35,751 | -34,623 | -33,229 |
| TOTAL | $2,717 | $3,761 | $3,875 | $4,954 | $6,283 |
| Total Liabilities And Equity | $4,989 | $6,249 | $4,298 | $5,610 | $7,156 |